JP Morgan Chase
SYRA

JP Morgan Chase’s Syra Health Corp. Class A Common Stock SYRA Stock Holding History

JP Morgan Chase’s Portfolio SYRA Stock Details SYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10
Closed -$14 – 7750
2024
Q2 		$14 Buy
10
+6
+150% +$8 ﹤0.01% 7191
2024
Q1 		$6 Buy
4
+2
+100% +$3 ﹤0.01% 7272
2023
Q4 		$2 Buy
+2
New +$3 ﹤0.01% 7476

Other funds holding SYRA

CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

JP Morgan Chase's SYRA Position: Q3 2024 in Review

JP Morgan Chase sold out of Syra Health Corp. Class A Common Stock (SYRA) in Q3 2024, closing a stake of 10 shares — an estimated $14 sold.

JP Morgan Chase first reported a position in SYRA in Q4 2023 and held it in 3 quarters. The position peaked at $14 in Q2 2024. 13 funds tracked by Wall St. Rank hold SYRA as of Q3 2024.

  • JP Morgan Chase reported no remaining Syra Health Corp. Class A Common Stock position as of Q3 2024 after selling out during the quarter.
  • JP Morgan Chase sold 10 Syra Health Corp. Class A Common Stock shares in Q3 2024, an estimated $14.
  • JP Morgan Chase first reported a position in Syra Health Corp. Class A Common Stock in Q4 2023 and held it in 3 quarters.
  • JP Morgan Chase's Syra Health Corp. Class A Common Stock position peaked at $14 in Q2 2024.
  • 13 funds tracked by Wall St. Rank held Syra Health Corp. Class A Common Stock as of Q3 2024.

Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.